Slideshow: in de kijker



Ontdek waarom 2016 een sleuteljaar was voor het UZ Gent

Lees meer

U bent hier: Skip Navigation LinksUZ Gent > Home > Agenda

Internationaal symposium: Primaire levertumoren

Tijdstip:

31 augustus 2017 11u15 - 01 september 2017 16u45

Doelgroep:

Chirurgen, hepatologen, radiologen en oncologen

Locatie:

Dept. of Surgery, Erasmus MC, PO Box 2040, 3000 CA Rotterdam

Contact persoon:

HPBRotterdam@erasmusmc.nl

Programma:

​Program:

Day 1, Thursday August 31 2017

  • 11.15-11.45 am: Welcome reception

  • 11.45-12.00 am: Welcome address - Jan Ijzermans, Rotterdam, The Netherlands and Rob de Man, Rotterdam, The Netherlands

  • 12.00-2.00 pm: Session 1: Hepatocellular carcinoma
    Chairs: Massimo Colombo, Milan Italy and Rob de Man, Rotterdam, The Netherlands

    • 12.00-12.30 pm: Epidemiology and screening of HCC - Massimo Colombo, Milan, Italy

    • 12.30-1.00 pm: Accuracy of imaging modalities - Francois Willemssen, Rotterdam, The Netherlands

    • 1.00-1.30 pm: BCLC criteria vs other prognostic systems for HCC patients. Western perspective - Umberto Cillo, Padova, Italy

    • 1.30-2.00 pm: Predicting HCC development - Philip Johnson, Liverpool, UK

  • 2.00-2.30 pm: Coffe break

  • 2.30-4.30 pm: Session 2: Surgical Treatment for HCC
    Chairs: Masatoshi Makuuchi, Tokyo, Japan and Wojcciech Polak, Rotterdam, The Netherlands

    • 2.30-3.00 pm: Riskassesment before liver surgery for HCC incirrhotic patients - Thomas Van Gulik, Amsterdam, The Netherlands

    • 3.00-3.30 pm: Boundaries in liver resection for HCC - Masatoshi Makuuchi, Tokyo, Japan

    • 3.30-4.00 pm: Deceased donor liver transplantation for HCC - Rene Adam, Paris, France

    • 4.00-4.30 pm: Living donor liver transplantation for HCC - Dieter Broering, Riyadh, Saudi Arabia

  • 4.30-5.00 pm: Coffee break

  • 5.00-7.30 pm: Session 3: Loco-regional Treatment in HCC
    Chairs: Bruno Sangro, Navarro, Spain and Adriaan Moelker, Rotterdam, The Netherlands

    • 5.00-5.30 pm: Advances and limitations ablation techniques for HCC - Otto van Delden, Amsterdam, The Netherlands

    • 5.30-6.00 pm: Transarterial radioembolisation - how does it affect our daily practice - Bruno Sangro, Navara, Spain

    • 6.00-6.30 pm: The role of TACE in the SIRT era - Adriaan Moelker, Rotterdam, The Netherlands

  • 7.30-22.30 pm: Networking

Day 2, Friday September 1 2017


  • 8.30-10.30 am: Session 4: Emerging Therapies for HCC
    Chairs: Alejandro Forner, Barcelona, Spain and Dave Sprengers, Rotterdam, The Netherlands

    • 8.30-9.00 am: Radiotherapy for HCC - Thomas Brunner, Freiburg, Germany

    • 9.00-9.30 am: Is proton therapy the new radiotherapy for HCC? - Alejandra Mendez Romero, Rotterdam, The Netherlands

    • 9.30-10.00 am: Immunotherapy in the treatment of HCC - Dave Sprengers, Rotterdam, The Netherlands

    • 10.00-10.30 am: Progress in systemic therapy of advanced hepatocellular carcinoma - Alejandro Forner, Barcelona, Spain

  • 10.30-11.00 am: Coffe break

  • 11.00-1.30 pm: Session 5: Innovations in Liver Tumor Diagnostics
    Chairs: Dan G. Duda, Boston, USA and Jan Ijzermans, Rotterdam, The Netherlands

    • 11.00-11.30 am: Diagnostic dilemmas in liver tumors - Valerie Vilgrain, Paris, France

    • 11.30-12.30 pm: Translation from molecular biology to clinical practice - Jessica Zucman-Rossi, Paris, France

    • 12.30-1.00 pm: The role of translational studies in clinical trials of liver cancers - Dan G. Duda, Boston, USA

    • 1.00-1.30 pm: Personalized approach using organoids in the treatment of liver tumors - Meritxell Huch, Utrecht, The Netherlands

  • 1.30-2.30 pm: Lunch

  • 2.30-4.30 pm: Session 6: Cholangiocarcinoma
    Chairs: ChristianToso, Geneva, Switzerland and Bas Groot Koerkamp, Rotterdam, The Netherlands

    • 2.30-3.00 pm: Epidemiology of hilar cholangiocarcinoma - Sarwa Darwish Murad, Rotterdam, The Netherlands

    • 3.00-3.30 pm: Difficulties in preoperative tumor assessment in hilar cholangiocarcinoma - Bas Groot Koerkamp, Rotterdam, The Netherlands

    • 3.30-4.00 pm: Surgical treatment of hilar cholangiocarcinoma (resection, ITx) - Christian Toso, Geneva, Switzerland

    • 4.00-4.30 pm: Advances in systemic therapy for cholangiocarcinoma - Arndt Vogel, Hannover, Germany

    • 4.30-4.45 pm: Closing remarks

  • 4.45 pm: Farewell

Practical:

U kan zich inschrijven via het inschrijvingsformulier
Meer info vindt u in de uitnodiging